Federal Register #FMCSA20260039

FMCSA Notice: Exemptions for Drivers with Epilepsy or Seizure Disorders

This notice from the Federal Motor Carrier Safety Administration (FMCSA) addresses regulatory exemptions for commercial drivers with epilepsy or seizure disorders. - Government Buyer: - Federal Motor Carrier Safety Administration (FMCSA), Department of Transportation - No OEMs or vendors are involved, as this is not a procurement action - No products or services are being requested or purchased - Key Requirements: - Renewal of exemptions for five individuals to operate commercial motor vehicles (CMVs) despite epilepsy or seizure disorders - Receipt of new exemption applications from eleven individuals - Exemptions require drivers to: - Remain seizure-free - Maintain stable anti-seizure medication treatment - Undergo annual medical examinations - Report any seizures, crashes, or disqualifying offenses - Submit annual certified driving records - Public comments are requested on new applications - Unique Aspects: - Focus on medical monitoring and compliance for individual drivers - No procurement, products, or vendors involved

Description

The Federal Motor Carrier Safety Administration (FMCSA) announces its decision to renew exemptions for five individuals from the Federal Motor Carrier Safety Regulations that prohibit interstate commercial motor vehicle drivers with epilepsy or seizure disorders from operating CMVs. These exemptions allow individuals who have had seizures and are on anti-seizure medication to continue driving in interstate commerce. The exemptions are valid from November 6, 2025, to November 6, 2027, and include specific terms and conditions such as remaining seizure-free, annual medical examinations, and reporting requirements. The notice also announces receipt of new exemption applications from 11 individuals and requests public comments by June 29, 2026.

View original listing